Evidence map›Paper›PMID 26739452›Full record

ArticleGenetics2016

Signaling Cascades Governing Cdc42-Mediated Chondrogenic Differentiation and Mensenchymal Condensation.

Jirong R Wang, Chaojun J Wang, Chengyun Y Xu, Xiaokai K Wu, Dun Hong, Wei Shi, Ying Gong, Haixiao X Chen, Fanxin Long, Ximei M Wu

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jirong R WangDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Chaojun J WangDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Chengyun Y XuDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Xiaokai K WuDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Dun HongDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Wei ShiDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Ying GongDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Haixiao X ChenDepartment of Orthopedics, Taizhou Hospital, Linhai 317000, China.
Fanxin LongDepartments of Orthopaedic Surgery, Medicine and Developmental Biology, Washington University, St. Louis, Missouri 63110.
Ximei M WuDepartment of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310058, China Departments of Orthopaedic Surgery, Medicine and Developmental Biology, Washington University, St. Louis, Missouri 63110 xiwu@zju.edu.cn.
Zhejiang University · CNWashington University in St. Louis · USZhejiang Taizhou Hospital · CN

Funding

Notch Signaling and Bone FormationR01AR055923 · NIAMS · WASHINGTON UNIVERSITY · PI LONG, FANXIN · 2008 to 2017
$3.5M
NIAMS NIH HHS R01 AR055923
6 · The paper itself

Abstract

Endochondral ossification consists of successive steps of chondrocyte differentiation, including mesenchymal condensation, differentiation of chondrocytes, and hypertrophy followed by mineralization and ossification. Loss-of-function studies have revealed that abnormal growth plate cartilage of the Cdc42 mutant contributes to the defects in endochondral bone formation. Here, we have investigated the roles of Cdc42 in osteogenesis and signaling cascades governing Cdc42-mediated chondrogenic differentiation. Though deletion of Cdc42 in limb mesenchymal progenitors led to severe defects in endochondral ossification, either ablation of Cdc42 in limb preosteoblasts or knockdown of Cdc42 in vitro had no obvious effects on bone formation and osteoblast differentiation. However, in Cdc42 mutant limb buds, loss of Cdc42 in mesenchymal progenitors led to marked inactivation of p38 and Smad1/5, and in micromass cultures, Cdc42 lay on the upstream of p38 to activate Smad1/5 in bone morphogenetic protein-2-induced mesenchymal condensation. Finally, Cdc42 also lay on the upstream of protein kinase B to transactivate Sox9 and subsequently induced the expression of chondrocyte differential marker in transforming growth factor-β1-induced chondrogenesis. Taken together, by using biochemical and genetic approaches, we have demonstrated that Cdc42 is involved not in osteogenesis but in chondrogenesis in which the BMP2/Cdc42/Pak/p38/Smad signaling module promotes mesenchymal condensation and the TGF-β/Cdc42/Pak/Akt/Sox9 signaling module facilitates chondrogenic differentiation.

Indexed as

Cell DifferentiationSignal TransductionAnimalsBone Morphogenetic Protein 2cdc42 GTP-Binding ProteinCells, CulturedChondrocytesChondrogenesisGene Expression Regulation, DevelopmentalGene Knockdown TechniquesMesenchymal Stem CellsMice, Inbred C3HMice, Inbred C57BLOsteoblastsOsteogenesisSOX9 Transcription FactorBone Morphogenetic Protein 2cdc42 GTP-Binding ProteinCdc42 protein, mouseSox9 protein, mouseSOX9 Transcription FactorTransforming Growth Factor betaCdc42chondrocytecondensationosteoblast

Identifiers

PMID26739452
PMCPMC4787953
OpenAlexW2296676426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.